BRVO · Form 3 · Marshall Steven Joseph – Bravo Multinational Inc.

⌘K

Filings	Filing Date	Form Type	Company	Description	AI	Link

BRVO · Form 3 · Marshall Steven Joseph – Bravo Multinational Inc. | Signal8

Insider transactionsFund filings

Sort

Filings				Description	AI	Link

Browse AI-analysed SEC filingsPage 1 of 77 · 7,646 total

HCA: 8-K · earnings releaseHCA · 8-K · 2026-10-27
SPGI: 8-K · earnings releaseSPGI · 8-K · 2026-10-27
IPHA: 6-K · clinical trialIPHA · 6-K · 2026-10-27
PHAR: 6-K · earnings releasePHAR · 6-K · 2026-10-27
IQV: 8-K · earnings releaseIQV · 8-K · 2026-10-27
GWRE: 8-K · acquisition mergerGWRE · 8-K · 2026-10-27
CNL: 6-K · clinical trialCNL · 6-K · 2026-10-27
GLXY: 8-K · earnings releaseGLXY · 8-K · 2026-10-27
SHW: 8-K · earnings releaseSHW · 8-K · 2026-10-27
RGEN: 8-K · earnings releaseRGEN · 8-K · 2026-10-27
AMT: 8-K · earnings releaseAMT · 8-K · 2026-10-27
SOFI: 8-K · earnings releaseSOFI · 8-K · 2026-10-27
ABG: 8-K · earnings releaseABG · 8-K · 2026-10-27
VBNK: 6-K · regulatory actionVBNK · 6-K · 2026-10-27
IAG: 6-K · otherIAG · 6-K · 2026-10-27
SMPL: 8-K · earnings releaseSMPL · 8-K · 2026-10-27
PYPL: 8-K · earnings releasePYPL · 8-K · 2026-10-27
MRX: 6-K · leadership changeMRX · 6-K · 2026-10-27
GLW: 8-K · earnings releaseGLW · 8-K · 2026-10-27
XYL: 8-K · earnings releaseXYL · 8-K · 2026-10-27
IVZ: 8-K · earnings releaseIVZ · 8-K · 2026-10-27
JAKK: 10-Q · periodic reportJAKK · 10-Q · 2026-10-27
AWI: 10-Q · periodic reportAWI · 10-Q · 2026-10-27
SNDL: 6-K · earnings releaseSNDL · 6-K · 2026-10-27
ODV: 6-K · otherODV · 6-K · 2026-10-27
CSHR: 6-K · share repurchaseCSHR · 6-K · 2026-10-27
MSCLF: 6-K · otherMSCLF · 6-K · 2026-10-27
KO: 8-K · earnings releaseKO · 8-K · 2026-10-27
JCI: 8-K · earnings releaseJCI · 8-K · 2026-10-27
PNR: 8-K · earnings releasePNR · 8-K · 2026-10-27
AZN: 6-K · fda approvalAZN · 6-K · 2026-10-27
RTO: 6-K · share repurchaseRTO · 6-K · 2026-10-27
MFIC: 8-K · acquisition mergerMFIC · 8-K · 2026-10-27
IVZ: 8-K · debt financingIVZ · 8-K · 2026-10-27
CMS: 8-K · earnings releaseCMS · 8-K · 2026-10-27
YMT: 424B3 · reverse splitYMT · 424B3 · 2026-10-27
FER: 6-K · material agreementFER · 6-K · 2026-10-27
HRI: 10-Q · periodic reportHRI · 10-Q · 2026-10-27
YMT: 6-K · reverse splitYMT · 6-K · 2026-10-27
VRT: 8-K · acquisition mergerVRT · 8-K · 2026-10-27
CPAC: 6-K · earnings releaseCPAC · 6-K · 2026-10-27
RCL: 8-K · earnings releaseRCL · 8-K · 2026-10-27
GM: 8-K · delistingGM · 8-K · 2026-10-27
SHG: 6-K · share repurchaseSHG · 6-K · 2026-10-27
ARCC: 10-Q · periodic reportARCC · 10-Q · 2026-10-27
FHN: 8-K · leadership changeFHN · 8-K · 2026-10-27
IMNN: S-1 · offering registrationIMNN · S-1 · 2026-10-27
CNP: 8-K · earnings releaseCNP · 8-K · 2026-10-27
TRU: 8-K · earnings releaseTRU · 8-K · 2026-10-27
AB: 8-K · earnings releaseAB · 8-K · 2026-10-27
BIDU: 6-K · earnings releaseBIDU · 6-K · 2026-10-27
BBVA: 6-K · regulatory actionBBVA · 6-K · 2026-10-27
ARCC: 8-K · earnings releaseARCC · 8-K · 2026-10-27
SHG: 6-K · share repurchaseSHG · 6-K · 2026-10-27
ARCC: 8-K · acquisition mergerARCC · 8-K · 2026-10-27
SHG: 6-K · earnings releaseSHG · 6-K · 2026-10-27
IX: 6-K · otherIX · 6-K · 2026-10-27
NVS: 6-K · earnings releaseNVS · 6-K · 2026-10-27
HCM: 6-K · clinical trialHCM · 6-K · 2026-10-27
ACRS: 8-K · clinical trialACRS · 8-K · 2026-10-27
UPS: 8-K · earnings releaseUPS · 8-K · 2026-10-27
HYMC: 8-K · earnings releaseHYMC · 8-K · 2026-10-27
ING: 6-K · share repurchaseING · 6-K · 2026-10-27
EQNR: 6-K · share repurchaseEQNR · 6-K · 2026-10-27
CNP: 10-Q · periodic reportCNP · 10-Q · 2026-10-27
WDS: 6-K · asset saleWDS · 6-K · 2026-10-27
HLT: 8-K · earnings releaseHLT · 8-K · 2026-10-27
IONR: 6-K · periodic reportIONR · 6-K · 2026-10-27
VBIO: 8-K · material agreementVBIO · 8-K · 2026-10-27
IBCP: 8-K · earnings releaseIBCP · 8-K · 2026-10-27
PG: 424B5 · prospectus supplementPG · 424B5 · 2026-10-27
AWI: 8-K · earnings releaseAWI · 8-K · 2026-10-27
NMR: 6-K · foreign private issuerNMR · 6-K · 2026-10-27
ATAT: 6-K · otherATAT · 6-K · 2026-10-27
TII: 6-K · otherTII · 6-K · 2026-10-27
REXR: 10-Q · periodic reportREXR · 10-Q · 2026-10-27
WETO: 6-K · amendmentWETO · 6-K · 2026-10-27
CNC: 10-Q · periodic reportCNC · 10-Q · 2026-10-26
CPAC: 6-K · earnings releaseCPAC · 6-K · 2026-10-26
CNC: 8-K · earnings releaseCNC · 8-K · 2026-10-26
BMOOF: 6-K · material agreementBMOOF · 6-K · 2026-10-26
ELE: 6-K · acquisition mergerELE · 6-K · 2026-10-26
BETR: 8-K · leadership changeBETR · 8-K · 2026-10-26
NAUT: 8-K · earnings releaseNAUT · 8-K · 2026-10-26
CMTV: 8-K · earnings releaseCMTV · 8-K · 2026-10-26
PII: 8-K · earnings releasePII · 8-K · 2026-10-26
EGO: 6-K · otherEGO · 6-K · 2026-10-26
BFH: 10-Q · periodic reportBFH · 10-Q · 2026-10-26
ELP: 6-K · leadership changeELP · 6-K · 2026-10-26
POAS: 6-K · otherPOAS · 6-K · 2026-10-26
AMGN: 8-K · leadership changeAMGN · 8-K · 2026-10-26
BCSF: 8-K · earnings releaseBCSF · 8-K · 2026-10-26
HYMC: 10-Q · periodic reportHYMC · 10-Q · 2026-10-26
BLX: 6-K · dividendBLX · 6-K · 2026-10-26
VLRS: 6-K · earnings releaseVLRS · 6-K · 2026-10-26
SNDL: 6-K · earnings releaseSNDL · 6-K · 2026-10-26
AURE: SCHEDULE 13D/A · ownership disclosureAURE · SCHEDULE 13D/A · 2026-10-27
GRML: S-1 · offering registrationGRML · S-1 · 2026-10-26
BEAG: 8-K · otherBEAG · 8-K · 2026-10-26
IQST: 8-K · debt financingIQST · 8-K · 2026-10-26